By Editor • August 19, 2026 • 1 min read
In a significant advance for oncology, Merck and Moderna announced positive results from a late-stage trial of their personalized mRNA cancer vaccine. This groundbreaking study demonstrates the potential effectiveness of mRNA technology in cancer treatment, marking a hopeful development for patients and researchers alike.
Source: www.statnews.com
By Editor • August 19, 2026 • 1 min read
STAT has launched an initiative to restore trust in science, appointing Nicholas Florko as a dedicated reporter to explore misinformation's origins and impact.
Read moreBy Editor • August 19, 2026 • 1 min read
Moderna and Merck's mRNA cancer vaccine shows promise in a Phase 3 trial for melanoma, highlighting advancements in personalized cancer treatment.
Read moreBy Editor • August 19, 2026 • 1 min read
Carole Kendall calls for improved pain relief for women undergoing hysteroscopies, comparing their treatment unfavorably to men's colonoscopy experiences.
Read more
